AACN
    IIBM
    IINFY
    CCTSH
    value investingIT ServicesAI Adoption

    Accenture: The Dividend Compounder Trading at a Value Price

    Accenture: The Dividend Compounder Trading at a Value Price
    • ACN trades at 14.4x forward earnings with a 100th-percentile EPS predictability score and 40x interest coverage. The market is pricing it like a utility. The business is still growing bookings at double digits.
    • The Chowder Rule on ACN is 16.2%, clearing the 15% quality compounder threshold. Forward yield of 3.0% combined with 13.1% five-year dividend growth rate makes the income case as strong as the value case.
    • Gen AI bookings at Accenture nearly doubled to $5.9B in FY25. The AI disruption narrative is backwards: enterprise clients are hiring ACN to implement AI, not replacing it with AI.
    • Blended fair value: $292. Current price near $213. That is a 27% discount on a business with Quality Score 94, Safety Score 97.36, and negative net working capital risk. Strong Buy zone is active.
    • The invalidation trigger is specific: two consecutive quarters of declining bookings plus a guidance cut below 2% FY26 revenue growth. Until that happens, the drawdown is price compression, not franchise deterioration.
    Glenn Ford
    Mar 10, 20263:19 PM3390

    By GNG Research | March 2026

    There is a particular kind of frustration that only value investors understand. You watch a great business get repriced violently lower, your screen lights up green across every fundamental metric, and yet the stock keeps falling. The tape is relentless. The narrative is brutal. Every instinct trained by years of momentum-chasing whispers to wait, to let it bottom, to find something cleaner.

    That frustration is exactly where Accenture (ACN) sits right now, and I think it is wrong to wait.

    Keep Reading

    Create a free account to access more content.

    Sign in to leave a comment and join the discussion.

    Sign Up Free